Sanatorio Finochietto

Buenos Aires C1187AAN

2 studies enrolling now · 6 studies all time

What they study most

Acute Coronary Syndrome, Acute Myocardial Infarction (AMI), Atrial Fibrillation, Cardiovascular Risk, Covid-19, Ischemic Stroke; Ischemic Attack, Transient, Peripheral Arterial Disease

Studies at this site

• Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• CPI-006 Plus Standard of Care Versus Placebo Plus Standard of Care in Mild to Moderately Symptomatic Hospitalized Covid-19 Patients — Stopped early